Compare CMC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMC | CRL |
|---|---|---|
| Founded | 1915 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 8.6B |
| IPO Year | 1994 | 1999 |
| Metric | CMC | CRL |
|---|---|---|
| Price | $77.35 | $187.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $73.33 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 918.1K | 788.2K |
| Earning Date | 03-26-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | ★ $7,918,430,000.00 | $1,857,601,000.00 |
| Revenue This Year | $18.81 | N/A |
| Revenue Next Year | $6.34 | $3.04 |
| P/E Ratio | $32.26 | ★ N/A |
| Revenue Growth | ★ 25.57 | 10.48 |
| 52 Week Low | $47.92 | $143.06 |
| 52 Week High | $84.87 | $228.88 |
| Indicator | CMC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 60.56 |
| Support Level | $67.83 | $161.39 |
| Resistance Level | $78.92 | $197.12 |
| Average True Range (ATR) | 2.52 | 8.43 |
| MACD | -0.03 | 1.82 |
| Stochastic Oscillator | 69.96 | 84.30 |
Commercial Metals Co is a manufacturer and supplier of early-stage construction materials, including steel reinforcing bars, concrete pipes, precast products, and soil stabilization solutions. It also produces merchant bar, steel fence posts, and wire rod, serving domestic and some international markets in Europe and Asia. Its products are used in infrastructure and building projects such as highways, bridges, airports, and commercial and residential buildings.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.